enprofylline and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide

enprofylline has been researched along with n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Bertarelli, DC; Borrmann, T; Florin, NC; Hinz, S; Li, W; Müller, CE; Scheiff, AB	1
Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E	1
Barawkar, DA; Basu, S; Bedse, G; Bonagiri, R; Chaturvedi, S; Chugh, A; Dusange, S; Ghosh, I; Goswami, A; Gundu, J; Jadhav, D; Karande, V; Kulkarni, A; Kumar, S; Menon, S; Mookhtiar, KA; Mukhopadhyay, P; Paliwal, S; Palle, VP; Panmand, A; Patel, M; Prasad, V; Quraishi, A; Ramdas, V; Reddy, BS; Rouduri, S; Thakre, R; Thorat, S; Waman, Y	1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G	1

Reviews

1 review(s) available for enprofylline and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide

Article	Year
Adenosine receptor antagonists: Recent advances and therapeutic perspective. European journal of medicinal chemistry, 2022, Jan-05, Volume: 227 Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship	2022

Other Studies

3 other study(ies) available for enprofylline and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide

Article	Year
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. Journal of medicinal chemistry, 2009, Jul-09, Volume: 52, Issue:13 Topics: Adenosine A2 Receptor Antagonists; Animals; Drug Design; Humans; Kinetics; Ligands; Mice; Protein Binding; Radioligand Assay; Rats; Receptor, Adenosine A2B; Xanthines	2009
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5 Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship	2016
A European journal of medicinal chemistry, 2017, Feb-15, Volume: 127 Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Receptor, Adenosine A2B; Structure-Activity Relationship; Xanthine	2017